Investing.com’s stocks of the week

Investing.com -- Markets concluded the week with a notable shift in sentiment. After reaching record highs earlier, U.S. stocks closed lower on Friday, impacted by macroeconomic concerns.

Here are Investing.com’s stocks of the week.

CoreWeave

CoreWeave shares declined significantly, trading around the $125.90 level as we approach Friday’s close, down over 21% in the last week.

The decline comes after it was announced on Monday that the company will acquire Core Scientific in an all-stock deal valued at approximately $9 billion.

Following the news, Barclays analysts said in a note that they are “constructive around the opportunity to vertically integrate data center operations, and believe the deal will give CoreWeave ample visibility into future HPC data center buildouts.”

Delta Air Lines (NYSE:DAL)

Delta Air Lines surged 12% on Thursday, climbing to its highest levels since March after the carrier reported strong second-quarter earnings, topping consensus expectations. 

Reacting to the results, Bernstein analysts said the company was “rekindling the sector bull case.”

“DAL reported solid 2Q results and re-established FY25 guidance that’s 8% ahead of consensus,” wrote the firm. “We’re expecting industry capacity discipline to support a stronger end of the year, rekindling optimism over the structural bull case.”

Delta shares are up around 13.3% in the last week.

WK Kellogg

KLG jumped significantly (+30.6%) on Thursday after Ferrero Group announced it will acquire the company for $23 per share in cash, representing a total enterprise value of $3.1 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

“Both the W.K. Kellogg Foundation Trust and Gund Family, which represent a combined 21.7% of the shareholder vote, support the transaction with Ferrero,” Stifel analysts noted. “We believe the transaction would provide scale to Ferrero North America’s center-of-store business and provide strong free cash flow following the supply chain investment cycle."

Rhythm Pharmaceuticals (NASDAQ:RYTM)

RYTM was another big mover this week after a 36.6% jump on Wednesday. The company’s shares have rallied 30.6% in the last week. 

The stock increase follows the biopharmaceutical firm’s announcement of positive results for its obesity drug. 

The company said the Phase 2 trial evaluating bivamelagon in patients with acquired hypothalamic obesity showed it “achieved statistically significant and clinically meaningful reductions in body mass index (BMI) at 14 weeks of treatment.

Following the news, Stifel said in a note to clients that the results “clearly show bivamelagon is a drug with efficacy that is in the ballpark of setmelanotide, thus offering compelling optionality for RYTM.”

Fair Isaac (NYSE:FICO) Corporation

FICO shares have declined by more than 17% in the last week after the FHFA Director Bill Pulte announced that Fannie Mae (OTC:FNMA) and Freddie Mac (OTC:FMCC) will now allow lenders to use VantageScore 4.0 for mortgage originations, effective immediately, while maintaining the existing tri-merge requirement.

On social media platform X, Pulte stated: "Effective today, to increase competition to the Credit Score Ecosystem and consistent with President Trump’s landslide mandate to lower costs, Fannie and Freddie will ALLOW lenders to use Vantage 4.0 Score with no current requirement to build new infrastructure (stays Tri Merge)."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

Wells Fargo cut its share price for FICO to $2,300 from $2,600, maintaining an Overweight rating on the stock in a note following the news. 

“Reflecting the increased regulatory scrutiny, we’re lowering our FICO estimates and PT given our concern that FICO will be more measured with its mortgage score prices,” wrote the bank.

Is DAL truely undervalued?

With DAL making headlines, investors are asking: Is it truly valued fairly? InvestingPro's advanced AI algorithms have analyzed DAL alongside thousands of other stocks to uncover hidden gems with massive upside. And guess what? DAL wasn't at the top of the list.

Unlock ProPicks AI